Fri, Dec 19, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Limmat Capital announces 9th consecutive profitable year for flagship strategy

Tuesday, February 04, 2014
Opalesque Industry Update - Striving to deliver consistent profits to investors, LIMMAT CAPITAL Alternative Investments AG, an independent FINMA regulated investment management firm in Zurich, Switzerland, specializing in liquid long/short equity and balanced fund strategies, achieved the ninth consecutive positive year. Further, Limmat Capital has produced a strong risk-adjusted return of 13% p.a. with a maximum draw-down of 5.3%, no down year and a lifetime Sharpe Ratio of 2.0 since inception in 2005.

"Our company has enjoyed such success thanks to our team's long-term trading experience, vast knowledge of the European markets and diverse backgrounds," said Limmat Capital CEO Raphael Rutz, who is also the company's co-founder and portfolio manager. "We are incredibly pleased to be recognized for our special emphasis on risk management and ability to generate stable returns and operational excellence."

Limmat Capital's flagship equity strategy employs a tactical long/short equity trading approach that uses both alpha and beta sources of return. The current strategy assets under management stand at CHF 120 million.

"Further keys to our performance include our combination of uncorrelated return streams across both short-term and medium-term time frames plus our active exposure management, a proven disciplined risk and portfolio management framework with strict loss management," Rutz added.

Limmat Capital's portfolio managers express their views through market directional trading positions, momentum and fundamental investing, as well as market-independent stock-specific event-driven positions. The teams' professional backgrounds include floor and proprietary trading, fundamental, quantitative and technical research, and hedge fund research and due diligence. The portfolio managers have an average of 24 years' experience in the financial industry.

"While 2013 was a challenging year for trading funds due to low volatility and the lack of larger trading ranges, Limmat Capital is optimistic about upcoming opportunities," said Ramon Huber, co-founder and co-portfolio manager.

"Looking back at 2013, monetary policy was the key driver of economic activity supporting asset price inflation. Looking into 2014, we are convinced more than ever that, as we move out of the hope phase and into the growth phase of the equity cycle, further gains in European equities need to be supported by earnings growth. We believe that the alpha generation should be a more important component to overall returns in the year ahead," added Frederick Barnard, head of research and co-portfolio manager.

Limmat Capital

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und